Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Matcha, a finely ground powdered green tea, is recognized for its rich content of catechins, particularly epigallocatechin gallate (EGCG), which have been studied for their potential lipid-lowering effects. Several scientific studies have investigated the impact of green tea and its extracts on lipid profiles, including triglyceride levels. A number of randomized controlled trials and meta-analyses suggest that green tea consumption can lead to modest reductions in serum triglycerides, likely due to its ability to enhance fat oxidation and improve metabolic health. For example, a 2011 meta-analysis published in the American Journal of Clinical Nutrition found that green tea catechin supplementation produced a significant decrease in triglyceride levels compared to placebo. The mechanisms proposed include inhibition of lipid absorption in the gut, upregulation of enzymes involved in lipid metabolism, and antioxidant effects reducing oxidative stress related to dyslipidemia. However, most studies use green tea extracts or substantial quantities of brewed green tea, and data specifically on matcha (which is more concentrated) are limited but likely comparable. While the evidence is promising, the overall effect size is moderate, and matcha should be considered a supportive dietary component rather than a primary therapy for hypertriglyceridemia. It is advisable to use matcha alongside other lifestyle modifications and medical treatments as recommended by healthcare professionals.

More about Matcha
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by Matcha

Products containing Matcha